Strand to Help Agilent 'Accelerate' GeneSpring Upgrade to Meet 'Evolving' Demand | GenomeWeb
NEW YORK (GenomeWeb News) — Strand Life Sciences will help Agilent accelerate the upgrade of its GeneSpring software in an attempt to meet “evolving customer needs,” Agilent said yesterday.
 
Terms of the deal call for Strand to employ its Avadis platform to “power the … GeneSpring products and enable rapid development of new functionality and analysis capabilities,” Stand CEO Vijay Chandru said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.